242 related articles for article (PubMed ID: 26400507)
21. BRCA carriers have similar reproductive potential at baseline to noncarriers: comparisons in cancer and cancer-free cohorts undergoing fertility preservation.
Gunnala V; Fields J; Irani M; D'Angelo D; Xu K; Schattman G; Rosenwaks Z
Fertil Steril; 2019 Feb; 111(2):363-371. PubMed ID: 30527950
[TBL] [Abstract][Full Text] [Related]
22. Combination of ovarian tissue harvesting and immature oocyte collection for fertility preservation increases preservation yield.
Hourvitz A; Yerushalmi GM; Maman E; Raanani H; Elizur S; Brengauz M; Orvieto R; Dor J; Meirow D
Reprod Biomed Online; 2015 Oct; 31(4):497-505. PubMed ID: 26278808
[TBL] [Abstract][Full Text] [Related]
23. Ovarian stimulation for fertility preservation in patients with cancer.
Quintero RB; Helmer A; Huang JQ; Westphal LM
Fertil Steril; 2010 Feb; 93(3):865-8. PubMed ID: 19013563
[TBL] [Abstract][Full Text] [Related]
24. Can highly sensitive antimüllerian hormone testing predict failed response to ovarian stimulation?
Burks HR; Ross L; Opper N; Paulson E; Stanczyk FZ; Chung K
Fertil Steril; 2015 Sep; 104(3):643-8. PubMed ID: 26158904
[TBL] [Abstract][Full Text] [Related]
25. Does type of cancer affect ovarian response in oncofertility patients?
Hussein RS; Zhao Y; Khan Z
J Gynecol Obstet Hum Reprod; 2021 Jun; 50(6):101944. PubMed ID: 33069914
[TBL] [Abstract][Full Text] [Related]
26. 450 IU versus 600 IU gonadotropin for controlled ovarian stimulation in poor responders: a randomized controlled trial.
Lefebvre J; Antaki R; Kadoch IJ; Dean NL; Sylvestre C; Bissonnette F; Benoit J; Ménard S; Lapensée L
Fertil Steril; 2015 Dec; 104(6):1419-25. PubMed ID: 26361207
[TBL] [Abstract][Full Text] [Related]
27. Antral follicle count (AFC) can be used in the prediction of ovarian response but cannot predict the oocyte/embryo quality or the in vitro fertilization outcome in an egg donation program.
Melo MA; Garrido N; Alvarez C; Bellver J; Meseguer M; Pellicer A; Remohí J
Fertil Steril; 2009 Jan; 91(1):148-56. PubMed ID: 18455166
[TBL] [Abstract][Full Text] [Related]
28. Random start ovarian stimulation before gonadotoxic therapies in women with cancer: a systematic review and meta-analysis.
Sönmezer M; Şükür YE; Ateş C; Saçıntı KG; Sönmezer M; Aslan B; Atabekoğlu CS; Özmen B; Oktay KH
Reprod Biomed Online; 2023 Dec; 47(6):103337. PubMed ID: 37857156
[TBL] [Abstract][Full Text] [Related]
29. Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment.
Domingo J; Guillén V; Ayllón Y; Martínez M; Muñoz E; Pellicer A; Garcia-Velasco JA
Fertil Steril; 2012 Apr; 97(4):930-4. PubMed ID: 22283969
[TBL] [Abstract][Full Text] [Related]
30. Comparison of Oocyte and Embryo Quality Between Random Start and Controlled Ovarian Stimulation Cycles in Cancer Patients Undergoing Fertility Preservation.
İsrafilova G; Şükür YE; Özkavukcu S; Sönmezer MA; Atabekoğlu CS; Özmen B; Berker B; Aytaç R; Koç A; Sönmezer M
Reprod Sci; 2021 Aug; 28(8):2200-2207. PubMed ID: 33409878
[TBL] [Abstract][Full Text] [Related]
31. Effective method for emergency fertility preservation: random-start controlled ovarian stimulation.
Cakmak H; Katz A; Cedars MI; Rosen MP
Fertil Steril; 2013 Dec; 100(6):1673-80. PubMed ID: 23987516
[TBL] [Abstract][Full Text] [Related]
32. Antral follicle count recovery in women with menses after treatment with and without gonadotropin-releasing hormone agonist use during chemotherapy for breast cancer.
Sinha N; Letourneau JM; Wald K; Xiong P; Imbar T; Li B; Harris E; Mok-Lin E; Cedars MI; Rosen MP
J Assist Reprod Genet; 2018 Oct; 35(10):1861-1868. PubMed ID: 30066303
[TBL] [Abstract][Full Text] [Related]
33. Dual trigger with gonadotropin-releasing hormone agonist and standard dose human chorionic gonadotropin to improve oocyte maturity rates.
Griffin D; Feinn R; Engmann L; Nulsen J; Budinetz T; Benadiva C
Fertil Steril; 2014 Aug; 102(2):405-9. PubMed ID: 24842671
[TBL] [Abstract][Full Text] [Related]
34. Oocyte accumulation for fertility preservation in women with benign ovarian tumours with a history of previous surgery, multiple or large cysts.
Legrand C; Keller L; Collinet P; Barbotin AL; Béhal H; Rubod C; Decanter C
Reprod Biomed Online; 2021 Aug; 43(2):205-214. PubMed ID: 34247989
[TBL] [Abstract][Full Text] [Related]
35. Fertility preservation after gonadotoxic treatments for cancer and autoimmune diseases.
Saito S; Yamada M; Yano R; Takahashi K; Ebara A; Sakanaka H; Matsumoto M; Ishimaru T; Utsuno H; Matsuzawa Y; Ooka R; Fukuoka M; Akashi K; Kamijo S; Hamatani T; Tanaka M
J Ovarian Res; 2023 Aug; 16(1):159. PubMed ID: 37563616
[TBL] [Abstract][Full Text] [Related]
36. Back-to-back random-start ovarian stimulation prior to chemotherapy to maximize oocyte yield.
Wald K; Cakmak H; Mok-Lin E; Cedars M; Rosen M; Letourneau J
J Assist Reprod Genet; 2019 Jun; 36(6):1161-1168. PubMed ID: 31127475
[TBL] [Abstract][Full Text] [Related]
37. Predicting the ovarian response: towards a determinant model and implications for practice.
Arvis P; Rongières C; Pirrello O; Lehert P
J Assist Reprod Genet; 2024 Jan; 41(1):213-222. PubMed ID: 37921971
[TBL] [Abstract][Full Text] [Related]
38. Ovarian response to stimulation for fertility preservation in women with hematologic cancer.
Brun T; Dion L; Jaillard S; Bales D; Domin M; Lavoué V; Levêque J; Houot R; Duros S
J Gynecol Obstet Hum Reprod; 2021 May; 50(5):101925. PubMed ID: 33010467
[TBL] [Abstract][Full Text] [Related]
39. Prospective assessment of follicular growth and the oocyte cohort after ovarian stimulation for fertility preservation in 90 cancer patients versus 180 matched controls.
Decanter C; Robin G; Mailliez A; Sigala J; Morschhauser F; Ramdane N; Devos P; Dewailly D; Leroy-Martin B; Keller L
Reprod Biomed Online; 2018 May; 36(5):543-551. PubMed ID: 29506861
[TBL] [Abstract][Full Text] [Related]
40. Optimum oocyte retrieved and transfer strategy in young women with normal ovarian reserve undergoing a long treatment protocol: a retrospective cohort study.
Chen YH; Xu XH; Wang Q; Zhang SD; Jiang LL; Zhang CL; Ge ZJ
J Assist Reprod Genet; 2015 Oct; 32(10):1459-67. PubMed ID: 26384107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]